UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study

The ocular surface, 2022-04, Vol.24, p.15-21

2022

Link zum Volltext

Verfügbarkeit prüfen

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5597

2023

Link zum Volltext

Verfügbarkeit prüfen

Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography

Ophthalmology (Rochester, Minn.), 2013-08, Vol.120 (8), p.1597-1603

2013

Link zum Volltext

Verfügbarkeit prüfen

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration (CABERNET)

Ophthalmology (Rochester, Minn.), 2013-08, Vol.120 (8), p.1597-1603

2013

Link zum Volltext

Verfügbarkeit prüfen

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2013-02, Vol.120 (2), p.317-327

2013

Link zum Volltext

Verfügbarkeit prüfen

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE)

Ophthalmology (Rochester, Minn.), 2013-02, Vol.120 (2), p.328-333

2013

Link zum Volltext

Verfügbarkeit prüfen

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration

Ophthalmology (Rochester, Minn.), 2012-07, Vol.119 (7), p.1425-1431

2012

Link zum Volltext

Verfügbarkeit prüfen

A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline

Clinical therapeutics, 2021-09, Vol.43 (9), p.1595-1607

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial

Ophthalmology (Rochester, Minn.), 2022-04, Vol.129 (4), p.379-387

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial

Clinical therapeutics, 2022-09, Vol.44 (9), p.1178-1186

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of head and neck cancer at academic centers

Otolaryngology-head and neck surgery, 2010-03, Vol.142 (3), p.463-463

Nau, Jeffrey

2010

Link zum Volltext

Verfügbarkeit prüfen

OC-01

Clinical ophthalmology (Auckland, N.Z.), 2023-03, Vol.17, p.725

2023

Link zum Volltext

Verfügbarkeit prüfen

Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET)

Ophthalmology (Rochester, Minn.), 2013-02, Vol.120 (2), p.317-327

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Ophthalmology (Rochester, Minn.), 2022-04, Vol.129 (4), p.379-387

2022

Link zum Volltext

Verfügbarkeit prüfen

OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2

Clinical ophthalmology (Auckland, N.Z.), 2023-01, Vol.17, p.725-734

2023

Link zum Volltext

Verfügbarkeit prüfen

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration: MERITAGE Study: Twelve-Month Safety and Efficacy Results

Ophthalmology (Rochester, Minn.), 2012-07, Vol.119 (7), p.1425-1431

2012

Link zum Volltext

Verfügbarkeit prüfen

A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease

Ophthalmology and therapy, 2022-08, Vol.11 (4), p.1551-1561

2022

Link zum Volltext

Verfügbarkeit prüfen

Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiography

Ophthalmology (Rochester, Minn.), 2013-02, Vol.120 (2), p.328-333

2013

Link zum Volltext

Verfügbarkeit prüfen

Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 24 safety and efficacy results

Retina (Philadelphia, Pa.), 2014-05, Vol.34 (5), p.874

2014

Link zum Volltext

Verfügbarkeit prüfen

Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD

Retina (Philadelphia, Pa.), 2009-02, Vol.29 (2), p.157

2009

Link zum Volltext

Verfügbarkeit prüfen

Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results

Retina (Philadelphia, Pa.), 2013-06, Vol.33 (6), p.1232

2013

Link zum Volltext

Verfügbarkeit prüfen

Association Between Age-Related Macular Degeneration and Sleep-Disordered Breathing

Nau, Jeffrey A

2017

Link zum Volltext
ProQuest

Optic nerve glioma in a patient with von Hippel-Lindau syndrome

Journal of pediatric ophthalmology and strabismus, 2003-01, Vol.40 (1), p.57

2003

Link zum Volltext

Verfügbarkeit prüfen

Exostoses of the external auditory canal

Ear, nose, & throat journal, 2010-06, Vol.89 (6), p.E25-E25

2010

Link zum Volltext

Verfügbarkeit prüfen

Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration

Retina (Philadelphia, Pa.), 2012-01, Vol.32 (1), p.10

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(73)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(86)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(45)
Humans
(41)
Male
(23)
Female
(21)
Biological And Medical Sciences
(17)
Medical Sciences
(16)
Ophthalmology
(16)
Aged
(14)
Middle Aged
(14)
Adult
(12)
Surgery
(12)
Treatment Outcome
(12)
Animals
(11)
Strontium Radioisotopes - Therapeutic Use
(8)
Dry Eye Disease
(7)
Aged, 80 And Over
(6)
Fluorescein Angiography
(6)
Gastroenterology
(6)
Laparoscopy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Ophthalmology
(11)
Retina
(4)
Spine
(4)
Surgical Endoscopy
(4)
Cancer Research
(3)
Clinical Ophthalmology
(2)
Clinical Therapeutics
(2)
Infection And Immunity
(2)
International Journal Of Sport Nutrition
(2)
Pediatric Research
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study

The SARS-CoV-2 Virus and the Cholinergic System: Spike Protein Interaction with Human Nicotinic Acetylcholine Receptors and the Nicotinic Agonist Varenicline

Epimacular brachytherapy for neovascular age-related macular degeneration (CABERNET): fluorescein angiography and optical coherence tomography

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration (CABERNET)

Epimacular Brachytherapy for Neovascular Age-related Macular Degeneration

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration (MERITAGE)

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration

A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial

Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial

Treatment of head and neck cancer at academic centers

OC-01

Epimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET)

Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease

OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2

Macular Epiretinal Brachytherapy in Treated Age-related Macular Degeneration: MERITAGE Study: Twelve-Month Safety and Efficacy Results

A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease

Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiography

Macular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 24 safety and efficacy results

Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD

Safety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-month results

Association Between Age-Related Macular Degeneration and Sleep-Disordered Breathing

Optic nerve glioma in a patient with von Hippel-Lindau syndrome

Exostoses of the external auditory canal

Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration

Suchergebnisse filtern